ProCE Banner Activity

Novel Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Slideset Download
Download these slides to review the most current clinical data on managing patients with BPDCN

Released: March 10, 2020

Expiration: March 09, 2021

No longer available for credit.

Share

Faculty

Eric Deconinck

Eric Deconinck, MD, PhD

Professor of Hematology
Université de Franche-Comté
Head, Hematology Department
Cancerology
Chu Besançon
Besançon, France

Roberto Lemoli

Roberto Lemoli, MD

Professor of Hematology
Department of Internal Medicine (Di.M.I.)
University of Genoa
Director, Clinic of Hematology
San Martino Hospital IRCCS
Genoa, Italy

Daniel Wiseman

Daniel Wiseman, MB ChB, PhD

Senior Leukaemia Research Fellow
Division of Cancer Sciences
The University of Manchester
Consultant Haematologist
Department of Haematology
The Christie NHS Foundation Trust
Manchester, United Kingdom

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Stemline Therapeutics

Faculty Disclosure

Primary Author

Eric Deconinck, MD, PhD

Professor of Hematology
Université de Franche-Comté
Head, Hematology Department
Cancerology
Chu Besançon
Besançon, France

Roberto Lemoli, MD

Professor of Hematology
Department of Internal Medicine (Di.M.I.)
University of Genoa
Director, Clinic of Hematology
San Martino Hospital IRCCS
Genoa, Italy

Daniel Wiseman, MB ChB, PhD

Senior Leukaemia Research Fellow
Division of Cancer Sciences
The University of Manchester
Consultant Haematologist
Department of Haematology
The Christie NHS Foundation Trust
Manchester, United Kingdom